VIRAL DYNAMICS AND EARLY VIRAL RESPONSE AT WEEK 4 IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON α2B AND RIBAVIRIN

被引：0
|
作者：
Loaeza del Castillo, Aurora [1 ]
Sixtos-Alonso, S. [1 ]
Sanchez-Avila, F. [1 ]
Uribe, M. [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1436
引用
收藏
页码：965A / 965A
页数：1
相关论文
共 50 条
  • [41] Peginterferon alpha-2b (PEG-IFN) plus ribavirin (RBV) in Brazilian patients with chronic hepatitis C: 12 week viral clearance.
    Goncales, FL
    Vigani, A
    Goncales, N
    Coelho, HS
    Paixao, J
    Rosa, H
    Barone, A
    Focaccia, R
    Lucia, M
    Perez, R
    Lobato, C
    Weirich, J
    Vila, R
    Giannella, ML
    HEPATOLOGY, 2002, 36 (04) : 588A - 588A
  • [42] Peginterferon α-2b plus ribavirin compared with interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C in Saudi patients commonly infected with genotype 4
    Alfaleh, FZ
    Hadad, Q
    Khuroo, MS
    Aljumah, A
    Algamedi, A
    Alashgar, H
    Al-Ahdal, MN
    Mayet, I
    Khan, MQ
    Kessie, G
    LIVER INTERNATIONAL, 2004, 24 (06) : 568 - 574
  • [43] Assessment of both virological response at week 4 and at week 12 optimizes prediction of treatment outcome in patients with chronic hepatitis C treated with peginterferon alfa-2b plus ribavirin
    Martinot-Peignoux, Michelle
    Maylin, Sarah
    Ripault, Marie Pierre
    Moucari, Rami
    Boyer, Nathalie
    Giuily, Nathalie
    Castelnau, Corinne
    Marcellin, Patrick
    HEPATOLOGY, 2007, 46 (04) : 374A - 375A
  • [44] Impact of early viral kinetics on pegylated interferon alpha 2b plus ribavirin therapy in Japanese patients with genotype 2 chronic hepatitis C
    Nomura, H.
    Miyagi, Y.
    Tanimoto, H.
    Ishibashi, H.
    JOURNAL OF VIRAL HEPATITIS, 2009, 16 (05) : 346 - 351
  • [45] Durability of the response to peginterferon-α2b and ribavirin in patients with chronic hepatitis C: a cohort study in the routine clinical setting
    Giordanino, Chiara
    Sacco, Marco
    Ceretto, Simone
    Smedile, Antonina
    Ciancio, Alessia
    Cariti, Giuseppe
    De Blasi, Tiziano
    Picciotto, Antonio
    Marenco, Simona
    Grasso, Alessandro
    Pirisi, Mario
    Smirne, Carlo
    Colletta, Cosimo
    Traverso, Antonio
    Mazzucco, Dario
    Ciccone, Giovannino
    Simondi, Daniele
    Rizzetto, Mario
    Saracco, Giorgio
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (01) : 52 - 58
  • [46] IL28B-BASED MODEL FOR PREDICTION OF WEEK 4 VIRAL RESPONSE IN PEGINTERFERON-alfa2a+RIBAVIRIN TREATED HEPATITIS C GENOTYPE 1&4. FINAL REPORT WEEK 4 OPTIM STUDY
    Romero-Gomez, M.
    de Cuenca, B.
    Baeyens, E.
    Garcia-Samaniego, J.
    Salmeron, J.
    Alonso, M. D. M.
    Buenestado, J.
    Munoz, R.
    Diago, M.
    Garcia, A.
    Minguez, C.
    Morano, L.
    Giron, J. A.
    Gonzalez-Garcia, J.
    Crespo, J.
    Planas, R.
    Turnes, J.
    Calleja, J. L.
    Sola, R.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S368 - S368
  • [47] Histological Response Study of Chronic Viral Hepatitis C Patients Treated With Interferon Alone or Combined With Ribavirin
    Prado, Kleber
    Patzina, Rosely
    Bergamaschi, Denise
    Focaccia, Roberto
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2008, 12 (05): : 362 - 367
  • [48] Durability of viral response to interferon ribavirin combination in patients with chronic hepatitis C
    Poynard, T
    McHutchison, J
    Davis, G
    Esteban, R
    Albrecht, J
    Ling, M
    Group, I
    JOURNAL OF HEPATOLOGY, 2001, 34 : 23 - 23
  • [49] Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
    Davis, GL
    Wong, JB
    McHutchison, JG
    Manns, MP
    Harvey, J
    Albrecht, J
    HEPATOLOGY, 2003, 38 (03) : 645 - 652
  • [50] Treatment and outcome of genotype 4 chronic hepatitis C patients with peginterferon alfa 2b and ribavirin in the clinical setting in Germany
    Huppe, Dietrich
    Zehnter, Elmar
    Manns, Michael P.
    Mauss, Stefan
    Teuber, Gerlinde
    Dahhan, Tarek
    Meyer, Ulrike
    Moller, Bernd
    Dikopoulos, Nektarios
    Witthoft, Thomas
    Brack, Jochen
    Stern, Marek
    Kaiser, Stephan
    Prinzing, Renate
    HEPATOLOGY, 2007, 46 (04) : 389A - 390A
12345